Skip to content

3D-printed hand orthotics for the management of spasticity in cerebral palsy

An equivalence trial comparing 3D-printed hand orthotics and conventional orthoses in maintaining the range of wrist extension and the management of spasticity among children with cerebral palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11890421
Enrollment
130
Registered
2018-02-02
Start date
2017-08-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children diagnosed with cerebral palsy Nervous System Diseases Cerebral palsy

Interventions

One hundred children <12 years old diagnosed with cerebral palsy will be recruited from a local rehabilitation hospital over the course of 6 months and invited to participate in the study. The interve

Sponsors

Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica - CONCYTEC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study will include children younger than 12 years with a diagnosis of spastic cerebral palsy who have a score of >1+ on the Ashworth scale. These criteria are applied because, at that age, children with cerebral palsy are at an age where there is a greater risk of suffering from deformities but also, they are preventable. Parents of children who meet the inclusion criteria should be able to understand the study objectives and not intend to move in the next 6 months. These criteria are applied as part of the information in the study will be obtained from the parents. If they are not able to understand the objectives of the study or plan to move, this will not allow adequate measurements or allow them to be attended in a timely manner in case of an emergency or adverse event.

Exclusion criteria

Exclusion criteria: This study will not include children who have undergone surgical intervention for the treatment of spasticity or who have indication for surgery to correct hand deformities. Neither will children who are currently receiving botulinum toxin for the treatment of spasticity or any other treatment for spasticity, including prior use of orthoses. The presence of allergic reactions to contact with orthotic material will also be considered as an exclusion criterion. These criteria are to be applied in order to ensure the orthoses effectiveness. If participants are already receiving some others treatments for spasticity, they will not require the use of orthoses. If during the study the participants require surgery or are prescribed the use of Botox, it will also be considered an exclusion criterion for the analysis of the study.

Design outcomes

Primary

MeasureTime frame
Wrist passive range of movement, measured in angles using a goniometer at baseline and after four months

Secondary

MeasureTime frame
1. Spasticity degree, measured using the Ashworth modified scale at baseline and after 4 months 2. Hand function, measured using the Manual Ability Classification System (MACS) in its Spanish version at baseline and after 4 months 3. Acceptability and usability of the 3D orthotics, assessed through interviews with parents after four months

Countries

Peru

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026